| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Karen Del Carmen Barboza Salgado, Rosiene Gomes de Freitas Nascimento, Pedro José Fernandes Nunes Coelho, Laser Antonio Machado Oliveira, Katiane de Oliveira Pinto Coelho Nogueir. Cannabidiol protects mouse hippocampal neurons from neurotoxicity induced by amyloid β-peptide Toxicology in vitro : an international journal published in association with BIBRA. 2024-06-20. PMID:38901785. |
in this context, our study focuses on the potential therapeutic use of cannabidiol (cbd), a non-psychotropic cannabinoid with antioxidant and anti-inflammatory effects. |
2024-06-20 |
2024-06-23 |
mouse |
| Mattias Persson, Robert Kronstrand, Michael Evans-Brown, Henrik Gree. In vitro activation of the CB Drug testing and analysis. 2024-06-19. PMID:38894658. |
in vitro activation of the cb semi-synthetic cannabinoids (sscs) including hexahydrocannabinol (hhc) are emerging on the drug market and sold openly as purportedly legal replacements for cannabis and Δ |
2024-06-19 |
2024-06-21 |
Not clear |
| Toula Kourgiantakis, Ragave Vicknarajah, Judith Logan, Travonne Edwards, Eunjung Lee, Shelley Craig, Ashima Kaura, Charmaine C Williams, Savannah Marshal. Understanding youth and young adult cannabis use in Canada post-legalization: a scoping review on a public health issue. Substance abuse treatment, prevention, and policy. vol 19. issue 1. 2024-06-18. PMID:38886804. |
cannabis use is linked with many adverse effects for youth and young adults including psychosis, anxiety, depression, respiratory distress, cannabinoid hyperemesis syndrome, and impaired cognitive performance. |
2024-06-18 |
2024-06-21 |
Not clear |
| Rahul Nachnani, Amy Knehans, Jeffrey D Neighbors, Paul T Kocis, Tzuo Lee, Kayla Tegeler, Thomas Trite, Wesley M Raup-Konsavage, Kent E Vran. Systematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and Frontiers in pharmacology. vol 15. 2024-06-13. PMID:38868665. |
the major cannabinoids (delta-9-tetrahydrocannabinol and cannabidiol) are metabolized by the same cytochrome p450 (cyp) enzymes that metabolize most prescription medications and xenobiotics (cyp3a4, cyp2c9, cyp2c19). |
2024-06-13 |
2024-06-15 |
Not clear |
| Prakash Acharya, Aakash Mishra, Sandip Kuikel, Aman Mishra, Robin Rauniyar, Kunjan Khanal, Amit Sharma Nepal, Sahil Thapaliy. Severe and rapidly changing hypophosphatemia in cannabinoid hyperemesis syndrome: a case report. Oxford medical case reports. vol 2024. issue 6. 2024-06-12. PMID:38860017. |
the increasing prevalence of cannabis worldwide requires awareness of a potential, less recognized, paradoxical entity, the cannabinoid hyperemesis syndrome (chs). |
2024-06-12 |
2024-06-14 |
Not clear |
| Si Huang, Laura Righetti, Frank W Claassen, Akash Krishna, Ming Ma, Teris A van Beek, Bo Chen, Han Zuilhof, Gert Ij Salentij. Ultrafast, Selective, and Highly Sensitive Nonchromatographic Analysis of Fourteen Cannabinoids in Cannabis Extracts, Δ8-Tetrahydrocannabinol Synthetic Mixtures, and Edibles by Cyclic Ion Mobility Spectrometry-Mass Spectrometry. Analytical chemistry. 2024-06-11. PMID:38862388. |
ultrafast, selective, and highly sensitive nonchromatographic analysis of fourteen cannabinoids in cannabis extracts, Δ8-tetrahydrocannabinol synthetic mixtures, and edibles by cyclic ion mobility spectrometry-mass spectrometry. |
2024-06-11 |
2024-06-14 |
Not clear |
| Si Huang, Laura Righetti, Frank W Claassen, Akash Krishna, Ming Ma, Teris A van Beek, Bo Chen, Han Zuilhof, Gert Ij Salentij. Ultrafast, Selective, and Highly Sensitive Nonchromatographic Analysis of Fourteen Cannabinoids in Cannabis Extracts, Δ8-Tetrahydrocannabinol Synthetic Mixtures, and Edibles by Cyclic Ion Mobility Spectrometry-Mass Spectrometry. Analytical chemistry. 2024-06-11. PMID:38862388. |
the diversity of cannabinoid isomers and complexity of cannabis products pose significant challenges for analytical methodologies. |
2024-06-11 |
2024-06-14 |
Not clear |
| Ivan Santos, M Beatriz P P Oliveira, Ana Casas, Javier Fidalgo, Hugo Almeid. Understanding the Potential of CBD for Health Benefits: an Overview. Current drug discovery technologies. 2024-06-07. PMID:38847170. |
cannabidiol (cbd) is a well-known cannabinoid with potential benefits, including reducing epilepsy seizures, alleviating anxiety, and obsessive-compulsive disorder (ocd) symptoms, aiding in tourette syndrome (a neurodevelopmental disorder), depression, sleep disorders, and promising in the treatment of cancer, pain relief, and heart health. |
2024-06-07 |
2024-06-10 |
Not clear |
| Conor H Murray, Brenda M Gannon, Peter J Winsauer, Ziva D Cooper, Marcus S Delatt. The development of cannabinoids as therapeutic agents in the United States. Pharmacological reviews. 2024-06-07. PMID:38849155. |
cannabinoids within the cannabis plant, known as phytocannabinoids, mediate cannabis' effects through interactions with the body's endogenous cannabinoid system. |
2024-06-07 |
2024-06-10 |
Not clear |
| David Shurtleff, Angela Arensdorf, Patrick C Still, Steven W Gust, Sekai Chideya, David Craig Hopp, Inna Belfe. The National Center for Complementary and Integrative Health (NCCIH) Priorities for Cannabis and Cannabinoid Research. The Journal of pharmacology and experimental therapeutics. 2024-06-06. PMID:38844364. |
the national center for complementary and integrative health (nccih) priorities for cannabis and cannabinoid research. |
2024-06-06 |
2024-06-10 |
Not clear |
| David Shurtleff, Angela Arensdorf, Patrick C Still, Steven W Gust, Sekai Chideya, David Craig Hopp, Inna Belfe. The National Center for Complementary and Integrative Health (NCCIH) Priorities for Cannabis and Cannabinoid Research. The Journal of pharmacology and experimental therapeutics. 2024-06-06. PMID:38844364. |
in addition, nccih's efforts and initiatives to facilitate and coordinate an nih research agenda focused on cannabis and cannabinoid research is described. |
2024-06-06 |
2024-06-10 |
Not clear |
| Alexis F League, Barkha J Yadav-Samudrala, Ramya Kolagani, Calista A Cline, Ian R Jacobs, Jonathan Manke, Micah J Niphakis, Benjamin F Cravatt, Aron H Lichtman, Bogna M Ignatowska-Jankowska, Sylvia Fittin. A helping HAND: therapeutic potential of MAGL inhibition against HIV-1-associated neuroinflammation. Frontiers in immunology. vol 15. 2024-06-05. PMID:38835765. |
cannabinoid anti-inflammatory effects are well documented, but therapeutic utility of cannabis remains limited due to its psychotropic effects, including alterations within brain regions encoding reward processing and motivation, such as the nucleus accumbens. |
2024-06-05 |
2024-06-07 |
human |
| Minxuan Li, Qinqin Wu, Foqin Guo, Yuzeng Ouyang, Deyong Ao, Shijun You, Yuanyuan Li. A versatile, rapid Agrobacterium-mediated transient expression system for functional genomics studies in cannabis seedling. Planta. vol 260. issue 1. 2024-06-05. PMID:38837044. |
cannabis (cannabis sativa l.) holds great promise in the medical and food industries due to its diverse chemical composition, including specialized cannabinoids. |
2024-06-05 |
2024-06-07 |
Not clear |
| S Olivia Vanegas, Arsalan Zaki, Caroline N Dealy, Steven G Kinse. The minor phytocannabinoid delta-8-tetrahydrocannabinol attenuates collagen-induced arthritic inflammation and pain-depressed behaviors. The Journal of pharmacology and experimental therapeutics. 2024-06-04. PMID:38834355. |
patients with arthritis report using cannabis for pain management, and the major cannabinoid Δ |
2024-06-04 |
2024-06-07 |
Not clear |
| Krisstina Gowin, Meri Muminovic, Suzanna M Zick, Richard T Lee, Christina Lacchetti, Ashwin Meht. Integrative Therapies in Cancer Care: An Update on the Guidelines. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. vol 44. issue 3. 2024-05-31. PMID:38820485. |
asco and the society for integrative oncology have collaborated to develop guidelines for the application of integrative approaches in the management of anxiety, depression, fatigue and use of cannabinoids and cannabis in patients with cancer. |
2024-05-31 |
2024-06-02 |
Not clear |
| Erin Noel Jordan, Ramin Shirali Hossein Zade, Stephanie Pillay, Paul van Lent, Thomas Abeel, Oliver Kayse. Integrated omics of Saccharomyces cerevisiae CENPK2-1C reveals pleiotropic drug resistance and lipidomic adaptations to cannabidiol. NPJ systems biology and applications. vol 10. issue 1. 2024-05-31. PMID:38821949. |
yeast metabolism can be engineered to produce xenobiotic compounds, such as cannabinoids, the principal isoprenoids of the plant cannabis sativa, through heterologous metabolic pathways. |
2024-05-31 |
2024-06-02 |
Not clear |
| Jaeseung Soh, Yonsu Kim, Jay Shen, Mingon Kang, Stefan Chaudhry, Tae Ha Chung, Seo Hyun Kim, Yena Hwang, Daniel Lim, Adam Khattak, Leora Frimer, Ji Won Yo. Trends of emergency department visits for cannabinoid hyperemesis syndrome in Nevada: An interrupted time series analysis. PloS one. vol 19. issue 5. 2024-05-29. PMID:38809874. |
accordingly, the incidence of emergency department visits due to cannabinoid hyperemesis syndrome in patients with chronic cannabis use has also increased. |
2024-05-29 |
2024-06-02 |
Not clear |
| Jaeseung Soh, Yonsu Kim, Jay Shen, Mingon Kang, Stefan Chaudhry, Tae Ha Chung, Seo Hyun Kim, Yena Hwang, Daniel Lim, Adam Khattak, Leora Frimer, Ji Won Yo. Trends of emergency department visits for cannabinoid hyperemesis syndrome in Nevada: An interrupted time series analysis. PloS one. vol 19. issue 5. 2024-05-29. PMID:38809874. |
we compared patients visiting the emergency department due to cannabinoid hyperemesis syndrome with those visiting the emergency department due to other causes except cannabinoid hyperemesis and estimated the impact of cannabis commercialization for recreational use. |
2024-05-29 |
2024-06-02 |
Not clear |
| Jaeseung Soh, Yonsu Kim, Jay Shen, Mingon Kang, Stefan Chaudhry, Tae Ha Chung, Seo Hyun Kim, Yena Hwang, Daniel Lim, Adam Khattak, Leora Frimer, Ji Won Yo. Trends of emergency department visits for cannabinoid hyperemesis syndrome in Nevada: An interrupted time series analysis. PloS one. vol 19. issue 5. 2024-05-29. PMID:38809874. |
a substantial increase in emergency department visits due to cannabinoid hyperemesis syndrome occurred in nevada, especially after the commercialization of recreational cannabis. |
2024-05-29 |
2024-06-02 |
Not clear |
| Daniel King, Ewa Greenier, Maya Caballero, Brett Morga. Integrating the ASRA Pain Medicine Cannabis Consensus Guidelines into Certified Registered Nurse Anesthetist Clinical Practice. AANA journal. vol 91. issue 4. 2024-05-29. PMID:38809193. |
the american association of nurse anesthesiology practice committee and subject matter experts recently evaluated newly published cannabis guidelines titled "asra pain medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids." |
2024-05-29 |
2024-06-03 |
human |